1. Background {#sec67660}
=============

*Staphylococcus aureus* is one of the most common human pathogens that are responsible for a vast spectrum of acute and chronic community and hospital acquired infections ([@A20025R1], [@A20025R2]). Anterior nares are the main reservoir of *S. aureus* in children and adults ([@A20025R3]). Asymptomatic colonization is common and 20% of the healthy population have nasal cavity colonization with *S. aureus* that is a major risk factor for different infections ([@A20025R4]). During previous investigations in different communities, the prevalence of nasal carriage of *S. aureus* in healthy children has been reported as 26.6-52.3% ([@A20025R5]-[@A20025R8]). Emergence of resistant *S. aureus* to current antibiotics and increased prevalence of methicillin resistant *S. aureus (*MRSA) are major obstacles for treatment of infections by this pathogen ([@A20025R9]). At first MRSA was reported during the 1960s, while, currently it is prevalent in health-care centers. In the past, colonization and infections by MRSA were limited to hospitals, but since the 1990s they frequently have been reported in healthy young community members ([@A20025R10]-[@A20025R13]). Skin and soft tissue infections and severe necrotizing pneumonias are well-known clinical syndromes of MRSA ([@A20025R14]). Identification of MRSA nasal carriers and use of control modalities has been recommended for prevention of community and hospital associated infections ([@A20025R15], [@A20025R16]).

Considering the substantial prevalence of antibiotic resistance, recognition of antibiotic susceptibility patterns is imperative for decolonization and treatment of *S. aureus* infections. Despite noticeable previous studies regarding the prevalence of nasal carriage of *S. aureus* and MRSA in healthy children, a few investigations have been carried out about their associated risk factors. In this survey, antibiotic susceptibility of isolated nasal *S. aureus* among healthy children and associated risk factors for nasal MRSA carriage were evaluated.

2. Objectives {#sec67661}
=============

The goal of this investigation was to determine the prevalence, associated risk factors and antibiotic resistance patterns among healthy children who were nasal carriers of MRSA.

3. Patients and Methods {#sec67666}
=======================

3.1. Study Population {#sec67662}
---------------------

In this cross-sectional study, 350 one-month to 14-year-old healthy children were evaluated between July 2012 and March 2013. Specimens were collected by cluster random sampling from four health-care centers in Kashan, Iran. The children had referred to the centers for vaccination, growth monitoring or periodic examinations. They were examined by a pediatrician. Children who had acute or chronic respiratory infections, chronic medical disorders, those who needed admission or emergency care, and cases with skin infections were excluded from the study. Informed consent was obtained from parents following explanations about the study. The accompanied parent was interviewed and a questionnaire was filled. The questionnaire contained demographic characteristics and risk factors associated with *S. aureus* and MRSA nasal carriage such as age, sex, number of individuals in the family, parental smoking, sleeping with parents, antibiotic usage and hospitalization during the past three months. The ethics committee of Kashan University of Medical Sciences approved the study (approval code 823). Sample size was calculated by consideration of the 28.4% prevalence for *S. aureus* nasal isolation ([@A20025R7]), (d = 0.07, α = 0.05 and design effect of 1.5).

3.2. Nasal Sample Collection and Bacterial Isolation {#sec67663}
----------------------------------------------------

Sampling was conducted by rotating a moistened sterile cotton swab with sterile saline in vestibule of both anterior nares twice. The collected swabs were inserted in Amies tube transport media with charcoal (HiMedia, Mumbai, India) at a temperature between 2-4ºC and transported to the microbiology laboratory of Kashan Shahid Beheshti hospital within four hours. Swabs were cultured on mannitol salt agar (MSA) (Merk, Germany) at 35ºC for 48 hours. Yellowish colonies growing on MSA were subcultured on blood agar (Merk, Germany) for 24 hours. Growing colonies were identified as *S. aureus* by morphology of colony, Gram staining, and catalase, coagulase and DNase production in tube tests ([@A20025R17], [@A20025R18]).

3.3. Antibiotic Susceptibility Pattern {#sec67664}
--------------------------------------

Screening test for antibiotic resistance was done on positive cultures by the Kirby-Bauer disc diffusion method according to the Clinical and Laboratory Standard Institute (CLSI) ([@A20025R19]). The incubated colonies on blood agar were transported by a sterile loop onto Mueller-Hinton agar (Merk, Germany) with the antibiotic containing discs (Mast, UK) placed on top for 24 hours at 35ºC. The discs included: cephalothin (30 µg), co-trimoxazole (1.25/23.75 µg), clindamycin (2 µg), oxacillin (1 µg), vancomycin (30 µg) and ciprofloxacin (5 µg). After an elapse of the mentioned time, the inhibition zones of isolates around the discs were measured and compared with standard guidelines. If the following inhibition zones were observed the sample was considered resistant; cephalothin ≤ 14 mm, co-trimoxazole ≤ 10 mm, clindamycin ≤ 14 mm, oxacillin ≤ 10 mm, vancomycin ≤ 14 mm and ciprofloxacin ≤ 15 mm ([@A20025R19]). American type culture collection (ATCC) 25923 *S. aureus* was used as the control isolate for antimicrobial susceptibility detection ([@A20025R19]).

Minimal inhibitory concentration (MIC) breakpoints of, cephalothin ≥ 32 µg/mL, co-trimoxazole ≥ M8/152 µg/mL, clindamycin ≥ 4 µg/mL, ciprofloxacin ≥ 4 µg/mL, oxacillin ≥ 4 µg/mL and vancomycin ≥ 16 µg/mL were considered resistant ([@A20025R19]). MICs were assessed by E-test strips (Liofilchem, Italy). E-test strips were applied to Mueller-Hinton agar plates, which were inoculated with a solution of strains with optical density of 0.5 McFarland standard, using sterile loops. The E-test MIC was measured at the bottom of the inhibition zone intersected by the E-test strip. After screening by the disc diffusion test, resistant strains were confirmed by the E-test. However, the E-test was performed for all *S. aureus* positive cultures to evaluate oxacillin and vancomycin resistance.

3.4. Statistical Analysis {#sec67665}
-------------------------

Data analysis was conducted by the SPSS statistical software, version 16. For descriptive results, frequencies and percentages were used. Demographic and associated risk factors for MRSA were analyzed by the Chi-square and Fisher\'s exact tests, odds ratios and confidence intervals. Data distributions were evaluated using the Kolmogorov-smirnov test. According to the abnormal distribution of age and number of individuals in the family, for their comparison with two independent groups the Mann-whitney U test was used. Some variables were entered in to multivariate logistic regression if bivariate analysis resulted a P value of less than 0.1. All P values were two-sided and those less than 0.05 were considered significant.

4. Results {#sec68280}
==========

Overall, 350 children with mean age of 7.06 ± 4.25 years and age range of one month to 14 years were evaluated. Half of the cases were males with the other half being females. Mean age was 7.29 ± 4.08 and 6.84 ± 4.42 years among females and males, respectively with no significant difference (P value 0.3). Frequency of ≤ 4, 5-9 and 10- 14 year-old groups was 114 (32.6%), 119 (34%) and 117 (33.4%), respectively.

Among all cases, 92 (26.3%) had positive nasal cultures for *S. aureus,*from which 30 (32.6%) cases were female and 62 (67.4%) male, with this difference being significant (P value \< 0.001). Mean age of positive and negative cultures was 6.65 ± 4.46 and 7.21 ± 4.14 years, respectively (P value 0.22). Risk factors associated with nasal *S. aureus* colonization are shown in [Table 1](#tbl17256){ref-type="table"}. From the positive cultures, 26.1% were sensitive to all antibiotics, 22.8% were resistant to one, 21.7% to two, 16.3% to three, 5.4% to four, 4.3% to five and 3.3% to six antibiotics. The most resistance rate was towards cephalothin (52.2%) and the least resistance rate was towards vancomycin (4.3%). Frequency of antibiotic resistance in nasal *S. aureus* carriers is indicated in [Table 2](#tbl17257){ref-type="table"}. Prevalence of MRSA among positive cultures was 35.9%. Male gender increased the odds ratio of MRSA carriage fourteen times (P value 0.001). The mean age of MRSA and methicillin sensitive *S. aureus* (MSSA) carriers didn\'t differ significantly (P value 0.116) yet the age group of ≤ 4 years was associated with MRSA colonization (P value 0.016).

There was a significant association between antibiotic use and admission during the recent three months (P value \< 0.001), number of individuals in the family (P value \< 0.001), sleeping with parents (P value 0.019) and parental smoking (P value \< 0.001) with MRSA nasal colonization. [Table 3](#tbl17258){ref-type="table"} represents associated risk factors and antibiotic susceptibility of MRSA nasal carriers.

###### Potential Risk Factors for *Staphylococcus aureus* Nasal Carriage Among Children

  Factors                                      Positive No. (%)   Negative No. (%)   P value    95% CI        OR
  -------------------------------------------- ------------------ ------------------ ---------- ------------- -------
  **Age group, y**                                                                   0.026      \-            \-
  ≤ 4                                          37 (40.2)          77 (29.8)                                   
  5-9                                          21 (22.8)          98 (38)                                     
  10-14                                        34 (37)            83 (32.2)                                   
  **Family size**                                                                    \< 0.001   7.09-22.65    12.68
  ≤ 4                                          38 (41.3)          232 (89.9)                                  
  4 \<                                         54 (58.7)          26 (10.1)                                   
  **Parental smoking**                                                               \< 0.001   11.99-49.64   24.4
  **Yes**                                      50 (54.3)          12 (4.7)                                    
  **No**                                       42 (45.7)          246 (95.3)                                  
  **Sleeping with parents**                                                          \< 0.001   1.82-4.9      2.98
  Yes                                          58 (63)            94 (36.4%)                                  
  No                                           34 (37)            164 (63.6)                                  
  **Admission in the previous three months**                                         \< 0.001   1.91-5.31     3.18
  Yes                                          41 (44.6)          52 (20.2)                                   
  No                                           51 (55.4)          206 (79.8)                                  
  **Antibiotic use in the previous months**                                          \< 0.001   4.47-13.04    7.63
  Yes                                          53 (57.6)          39 (15.1)                                   
  No                                           39 (42.4)          219 (84.9)                                  
  **Gender**                                                                         \< 0.001   1.61-4.37     2.65
  Female                                       30 (32.6)          145 (56.2)                                  
  Male                                         62 (67.4)          113 (43.8)                                  

###### Frequency of Antibiotic Susceptibility in Nasal *Staphylococcus aureus* Carriers

  Antibiotics          Sensitive    Resistant
  -------------------- ------------ ------------
  **Cephalothin**      44 (47.8%)   48 (52.2%)
  **Co-trimoxazole**   61 (66.3%)   31 (33.7%)
  **Ciprofloxacin**    68 (73.9%)   24 (26.1%)
  **Clindamycin**      68 (73.9%)   24 (26.1%)
  **Oxacillin**        59 (64.1%)   33 (35.9%)
  **Vancomycin**       88 (95.7%)   4 (4.3%)

###### Univariate and multivariate analysis of variables and antibiotic susceptibility of nasal MRSA and MSSA *Staphylococcus aureus* carriage among children ^[a](#fn14124){ref-type="table-fn"}^

  Variables                                            Methicillin Resistance   P value      Logistic Regression                       
  ---------------------------------------------------- ------------------------ ------------ --------------------- ------------------- ----------
  **Gender**                                                                                 \< 0.001              14 (3.07-63.91)     0.001
  Male                                                 31 (52.5)                31 (93.9)                          ≤                   
  Female                                               28 (47.5)                2 (6.1)                                                
  **Age, y, Mean ± SD**                                7.3 ± 4.42               5.5 ± 4.66   0.12                  \-                  \-
  **Number of individuals in the family, Mean ± SD**   4.3 ± 0.97               5.3 ± 0.78   \< 0.001              \-                  \-
  **Antibiotic use in the previous three months**                                            \< 0.001              7.62 (2.58-22.5)    \< 0.001
  Yes                                                  25 (42.4)                28 (84.8)                                              
  No                                                   34 (57.6)                5 (15.2%)                                              
  **Admission during the previous three months**                                             \< 0.001              6.6 (2.55-17.05)    \< 0.001
  Yes                                                  17 (28.8)                24 (72.7)                                              
  No                                                   42 (71.2)                9 (27.3)                                               
  **Family size**                                                                            \< 0.001              9.9 (3.07-31.64)    \< 0.001
  ≤ 4                                                  34 (57.6)                4 (12.1)                                               
  \> 4                                                 25 (42.4)                29 (87.9)                                              
  **Age groups (years)**                                                                     0.016                 \-                  \-
  ≤ 4                                                  18 (30.5)                19 (57.6)                                              
  5-9                                                  18 (30.5%)               3 (9.1)                                                
  10-14                                                23 (39)                  11 (33.3)                                              
  **Parental smoking**                                                                       \< 0.001              7.04 (2.52-19.69)   \< 0.001
  Yes                                                  23 (39)                  27 (81.8)                                              
  No                                                   36 (61)                  6 (18.2)                                               
  **Sleeping with parents**                                                                  0.019                 3.13 (1.18-8.34)    0.022
  Yes                                                  32 (54.2)                26 (78.8)                                              
  No                                                   27 (45.8)                7 (21.2)                                               
  **Cephalothin resistance**                                                                 0.003                 3.89 (1.54-9.81)    0.004
  Sensitive                                            35 (59.3)                9 (27.3)                                               
  Resistant                                            24 (40.7)                24 (72.7)                                              
  **Co-trimoxazole resistance**                                                              0.074                 2.24 (0.92-5.48)    0.077
  Sensitive                                            43 (72.9)                18 (54.5)                                              
  Resistant                                            16 (27.1)                15 (45.5)                                              
  **Ciprofoxacin resistance**                                                                0.03                  2.84 (1.09-7.39)    0.033
  Sensitive                                            48 (81.4)                20 (60.6)                                              
  Resistant                                            11 (18.6)                13 (39.4)                                              
  **Clindamycin resistance**                                                                 0.002                 4.63 (1.73-12.42)   0.002
  Sensitive                                            50 (84.7)                18 (54.5)                                              
  Resistant                                            9 (15.3)                 15 (45.5)                                              
  **Vancomycin resistance**                                                                  0.015                 \-                  \-
  Sensitive                                            59 (100)                 29 (87.9)                                              
  Resistant                                            0 (0)                    4 (12.1)                                               
  **Multi drug resistant**                                                                   \< 0.001              8.65 (3.13-23.9)    \< 0.001
  Yes                                                  8 (13.6)                 19 (57.6)                                              
  No                                                   51 (86.4)                14 (42.4)                                              

^a^ MSSA, methicillin-sensitive *Staphylococcus aureus*, MRSA, methicillin-resistant *Staphylococcus aures*, OR, odds ratio, CI, confidence interval.

5. Discussion {#sec67667}
=============

According to this study, prevalence of nasal colonization with *S. aureus* among one-month to fourteen-year-old children was 26.3%. In a survey by Tabbarai et al. ([@A20025R19]) on 1193 school-aged children, prevalence of nasal carriage was 16.3%, out of which 34.8% were MRSA, while peak age of nasal carriage was 6-12 years old and vancomycin resistance rate was 1.7%. Ciftci et al. ([@A20025R7]) in Turkey worked on four to six-year-old children and reported 28.4% for the prevalence of nasal colonization which was consistent with our investigation. In Taiwan, prevalence of nasal colonization among two to 60-month-old children was 23.2% of which MRSA was present in 7.8% of cases and peak age of MRSA was two to six months old. Furthermore, day care attendance and family size were risk factors for MRSA nasal carriage ([@A20025R20]).

In our study, MRSA carriage was more than that of the Taiwanese report but risk factors were comparable. Other studies have reported the prevalence of nasal *S. aureus* colonization as 32.1% in South Korea, 40% in Tanzania and 18.1% in USA ([@A20025R5], [@A20025R6], [@A20025R21]), which were inconsistent with our study. The different in prevalence of nasal carriage between our study and others may be due to the various age groups studied. For example, two different surveys carried our during 2009 and 2010 in India, reported that nasal carriage among 5-15 and 1-5 year-old children was 52.3% and 6.3%, respectively ([@A20025R8], [@A20025R17]). Furthermore, other characteristics such as socioeconomic status were not determined in these studies.

In the present study, MRSA prevalence among positive nasal cultures was 35.9%, which was compatible with the study by Tabbarai et al. ([@A20025R19]) (34.8%). In other investigations, MRSA prevalence among healthy *S. aureus* nasal carriers varied from 0.3% ([@A20025R7]) to 18.9% ([@A20025R6]) that was significantly lower than our survey. Furthermore, even in societies with prevalence of 40% and 52.3% for nasal colonization, MRSA prevalence has been reported as 10.5% and 3.89%, respectively ([@A20025R5], [@A20025R8]). In the present study, the highest susceptibility of MRSA was towards vancomycin and the least sensitivity was towards cephalothin. Huang et al. ([@A20025R20]) detected no MRSA resistance to vancomycin and teicoplanin while 99.1% resistance to penicillin and 9% sensitivity to clindamycin (54.5% in our study) was reported. Concordant results have been reported by some researches ([@A20025R6], [@A20025R17]) yet MRSA clindamycin susceptibility in the investigation of ko et al. ([@A20025R6]) was 61.1% which was more than our study and other mentioned reports. In this study, prevalence of vancomycin sensitive MRSA was 87.9%, while in other studies this was reported as 100% ([@A20025R6], [@A20025R17], [@A20025R20]).

Comparison of the present research with previous studies indicates more judicious antibiotic prescription is needed for children. Although the vast majority of children with community acquired MRSA nasal colonization are self-limited during a one-year period ([@A20025R22]), some of them are at risk of recurrent skin and soft tissue infections thus decolonization of these cases is recommended ([@A20025R23]-[@A20025R25]). Furthermore, with regards to the high prevalence of nasal carriage of MRSA in our investigation, decolonization of healthy preschool children is prudent.

This study revealed that male gender, antibiotic use and hospitalization during the past three months, number of individuals in the family being more that four, age group of less than four years, parental smoking and sleeping with parent were associated risk factors for MRSA nasal carriage among healthy children. A few researches have been conducted regarding the risk factors of MRSA nasal carriage among healthy children. Fritz et al. ([@A20025R22], [@A20025R23]) identified some risk factors for nasal carriage of MRSA in healthy children that included outpatient visit in the past six months, surgery during the previous one year, history of immune deficiency and systemic infections, more than two people per bedroom (crowded home), a household member working at a health care center, a household member aged 19 to 27 years old or more than 60 years old and daycare attendance. Furthermore, the relationship with close contacts such as sharing a bath towel with MRSA nasal carriage was ruled out ([@A20025R26]) which appeared incompatible with our findings (close contact via sleeping with parents was associated with MRSA nasal colonization). Some studies have claimed that the household member who works at a hospital is the only risk factor for nasal MRSA carriage ([@A20025R27], [@A20025R28]). Pathak et al. ([@A20025R17]) concluded that a large family size was associated with *S. aureus* nasal carriage but recent hospitalization was not. Oppositely, we found that large family size and recent admission were risk factors of carriage.

Our study has some limitations, firstly, it was cross-sectional and didn\'t differentiate persistent from transient nasal colonization, thus obtaining another nasal culture after one year (cohort design) is recommended to detect persistent carriage over time, which is a major source of community infections. Secondly, it is possible that the isolated strains are not representative of the community and investigations with larger sample sizes are needed in the future. Thirdly, the family socioeconomic status was not evaluated in our research and it would be better to consider this in future studies. Fourthly, we did not confirm MRSA by mecA genes and also didn\'t find a Vancomycin-resistant *S. aureus* (VRSA) gene, thus more investigations in this field are imperative. Lastly, the impact of seasonal changes on *S. aureus* nasal colonization was not evaluated in our study, thus further studies are recommended.

In conclusion, in the present study the prevalence of nasal *S. aureus* colonization was 26.3% out of which 35.9% were MRSA. Furthermore, male sex, antibiotic use and admission in the past three months, crowded family, parental smoking and sleeping with parents were factors associated with MRSA nasal carriage.
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